87 Results for "

complement C3

" in MedChemExpress (MCE) Product Catalog:
Products (87)

87 Results for "complement C3" in MCE Product Catalog:

13
13 Publications Verification
Referencia número: HY-127105
No. CAS: 1644670-37-0
Pureza:  99.93%
Synonyms: LNP023
Target:  

Complement System

Áreas de investigación:  

Metabolic Disease Inflammation/Immunology

Iptacopan (LNP023) is an effective and orally-active highly selective factor B inhibitor with an IC50 value of 10 nM and KD of 7.9 nM. Iptacopan exerts a proximal effect in the complement cascade reaction, preventing the destruction (hemolysis) of red blood cells in PNH and the damage of renal cells in IgAN and C3G. Iptacopan can be used for the study of complement-mediated diseases, particularly paroxysmal nocturnal hemoglobinuria (PNH), primary immunoglobulin A nephropathy (IgAN), and complement 3 glomerulopathy (C3G) .
loading...
    loading...
13
13 Publications Verification
Referencia número: HY-127105A
No. CAS: 1646321-63-2
Pureza:  99.83%
Synonyms: LNP023 hydrochloride
Target:  

Complement System

Áreas de investigación:  

Metabolic Disease Inflammation/Immunology

Iptacopan (LNP023) hydrochloride is an effective and orally-active highly selective factor B inhibitor with an IC50 value of 10 nM and KD of 7.9 nM. Iptacopan hydrochloride exerts a proximal effect in the complement cascade reaction, preventing the destruction (hemolysis) of red blood cells in PNH and the damage of renal cells in IgAN and C3G. Iptacopan hydrochloride can be used for the study of complement-mediated diseases, particularly paroxysmal nocturnal hemoglobinuria (PNH), primary immunoglobulin A nephropathy (IgAN), and complement 3 glomerulopathy (C3G) .
loading...
    loading...
9
9 Cited Publications
Referencia número: HY-138161
No. CAS: 2411440-41-8
Pureza:  99.59%
Target:  

Complement System

Áreas de investigación:  

Inflammation/Immunology

JR14a is a potent thiophene antagonist of human complement C3a receptor. JR14a shows selectivity for the human C3a receptor over C5a receptor. JR14a can suppress C3aR-mediated inflammation .
loading...
    loading...
9
9 Cited Publications
Referencia número: HY-106178
No. CAS: 219639-75-5
Pureza:  99.98%
Synonyms: 3D53
Target:  

Complement System

Áreas de investigación:  

Cardiovascular Disease Inflammation/Immunology Cancer

PMX-53 (3D53) is a synthetic peptidic and a potent and orally active complement C5a receptor (CD88) antagonist with an IC50 of 20 nM. PMX-53 is also a low-affinity MrgX2 agonist that stimulates MrgX2-mediated mast cell degranulation. PMX-53 specifically binds to C5aR1 and does not bind to the second C5aR (C5L2) and C3aR. PMX-53 has anti-inflammatory, anticancer and antiatherosclerotic effects .
loading...
    loading...
8
8 Cited Publications
Referencia número: HY-P7863
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMucomplement C3/C3a; complement Component C3a; Anaphylatoxin; C3a
Species:  
Source:  
loading...
    loading...
7
7 Cited Publications
Referencia número: HY-P1717
No. CAS: 1427001-89-5
Synonyms: Cp40
Áreas de investigación:  

Inflammation/Immunology

AMY-101 (Cp40), a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring periodontitis in non-human primates (NHPs). AMY-101 (Cp40) exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation .
loading...
    loading...
7
7 Cited Publications
Referencia número: HY-P1717B
Synonyms: Cp40 acetate
Áreas de investigación:  

Inflammation/Immunology

AMY-101 acetate (Cp40 acetate), a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring periodontitis in non-human primates (NHPs). AMY-101 acetate (Cp40 acetate) exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation .
loading...
    loading...
7
7 Cited Publications
Referencia número: HY-P1717A
No. CAS: 1789738-04-0
Synonyms: Cp40 TFA
Áreas de investigación:  

Inflammation/Immunology

AMY-101 TFA (Cp40 TFA), a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring periodontitis in non-human primates (NHPs). AMY-101 (Cp40) exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-P7862
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHucomplement C3/C3a; complement Component C3a; C3a; Anaphylatoxin
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-P1036
No. CAS: 206645-99-0
Target:  

Complement System

Áreas de investigación:  

Others

Compstatin, a 13-residue cyclic peptide, is a potent inhibitor of the complement system C3 with species specificity. Compstatin binds to baboon C3 and is resistant to proteolytic cleavage in baboon blood (similar to humans). Compstatin inhibits only the activation of primates’ complement system. Compstatin exhibits IC50 values of 63 μM and 12 μM for classical and alterative complement pathway, respectively .
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-P1036A
Target:  

Complement System

Áreas de investigación:  

Others

Compstatin TFA, a 13-residue cyclic peptide, is a potent inhibitor of the complement system C3 with species specificity. Compstatin TFA binds to baboon C3 and is resistant to proteolytic cleavage in baboon blood (similar to humans). Compstatin TFA inhibits only the activation of primates’ complement system. Compstatin TFA exhibits IC50 values of 63 μM and 12 μM for classical and alterative complement pathway, respectively .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-N9481
No. CAS: 56411-57-5
Lipoteichoic acid is an orally effect anti-inflammatory and antitumor agent. Lipoteichoic acid is a crucial immune molecule in Gram-positive bacteria that activates the complement system by inducing C3 and inhibiting CD55. Lipoteichoic acid regulates macrophage autophagy through the PI3K/Akt/mTOR pathway. Lipoteichoic acid induces lung damage in mice. Lipoteichoic acid inhibits the production of melanin .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-P1345A
Target:  

Complement System

Áreas de investigación:  

Neurological Disease Endocrinology

TLQP-21 TFA, a VGF-derived peptide endowed of endocrine and extraendocrine properties, is a potent G-protein-coupled receptor complement-3a receptor1 (C3aR1) agonist (EC50: mouse TLQP-21=10.3 μM; human TLQP-21=68.8μM). TLQP-21 TFA activates C3aR1 to induce an increase of intracellular Ca 2+. TLQP-21 TFA is used for the research in regulation of nociception and other relevant physiologic functions .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P3252A
Target:  

Complement System

Áreas de investigación:  

Inflammation/Immunology

Pegcetacoplan acetate is a pegylated complement C3/C3b inhibitor. Pegcetacoplan acetate acts by specifically binding to and inhibiting C3 and C3b, thereby suppressing the complement cascade at its proximal stage. Pegcetacoplan is not a known inhibitor or inducer of CYP450 isoenzymes. Pegcetacoplan acetate can be used for the research of complement-mediated diseases, including paroxysmal nocturnal hemoglobinuria (PNH) and age-related macular degeneration (AMD) .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P99905
No. CAS: 2375661-82-6
Synonyms: IBI302

Target:  

VEGFR

Áreas de investigación:  

Cardiovascular Disease Neurological Disease

Efdamrofusp alfa is a bispecific fusion protein. Efdamrofusp alfa is capable of neutralizing both VEGF isoforms and C3b/C4b. Efdamrofusp alfa can be used for the research of neovascular age-related macular degeneration (nAMD) and other complement-related ocular conditions .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P3204
No. CAS: 934461-40-2
Synonyms: AL-78898A
Target:  

Complement System

Áreas de investigación:  

Metabolic Disease

POT-4 (AL-78898A), a Compstatin derivative, is a potent inhibitor of complement factor C3 activation. POT-4 can be used for age-related macular degeneration research
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P1505A
Synonyms: complement 3a (70-77) TFA
Target:  

Complement System

Áreas de investigación:  

Inflammation/Immunology

C3a (70-77) TFA (Complement 3a (70-77) TFA) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P74375
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: complement C2; C3/C5 convertase; C2
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P72137
Pureza:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Cfb; Bf; H2-Bfcomplement factor B; EC 3.4.21.47; C3/C5 convertase; complement factor B Ba fragment; complement factor B Bb fragment
Species:  
Source:  
loading...
    loading...
Referencia número: HY-NP004
Synonyms: CVF
Cobra Venom Factor (CVF) is a selective activator targeting complement components C3, C5, and factor B in the complement system. After binding to factor B, Cobra Venom Factor is cleaved by factor D, forming a stable C3/C5 convertase resistant to regulatory proteins H and I. This continuously hydrolyzes C3 and C5, depleting serum complement while inducing neutrophil migration, vascular leakage, and increased TNF-α levels. Cobra Venom Factor can be used to deplete complement and mimic complement activation-related pathological states, and is applied in animal models of complement-mediated diseases such as acute respiratory distress syndrome (ARDS), sepsis, and shock. Cobra Venom Factor can be isolated from the venom of cobras (e.g., Naja atra, Naja melanoleuca, Naja kaouthia, etc.) .
loading...
    loading...